NO944161D0 - Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel - Google Patents
Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddelInfo
- Publication number
- NO944161D0 NO944161D0 NO944161A NO944161A NO944161D0 NO 944161 D0 NO944161 D0 NO 944161D0 NO 944161 A NO944161 A NO 944161A NO 944161 A NO944161 A NO 944161A NO 944161 D0 NO944161 D0 NO 944161D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- drug
- carboxylic acid
- acid esters
- substituted heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4337270A DE4337270A1 (de) | 1993-11-02 | 1993-11-02 | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE19944434288 DE4434288A1 (de) | 1994-09-26 | 1994-09-26 | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
Publications (3)
Publication Number | Publication Date |
---|---|
NO944161D0 true NO944161D0 (no) | 1994-11-01 |
NO944161L NO944161L (no) | 1995-05-03 |
NO302028B1 NO302028B1 (no) | 1998-01-12 |
Family
ID=25930886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944161A NO302028B1 (no) | 1993-11-02 | 1994-11-01 | Substituerte heterocykliske karboksylsyreamidestere og deres anvendelse for fremstilling av legemidler |
Country Status (21)
Country | Link |
---|---|
US (1) | US5658933A (no) |
EP (1) | EP0650960B1 (no) |
JP (1) | JPH07224039A (no) |
KR (1) | KR950014069A (no) |
CN (1) | CN1084736C (no) |
AT (1) | ATE149485T1 (no) |
AU (1) | AU689135B2 (no) |
CA (1) | CA2134865A1 (no) |
CZ (1) | CZ287767B6 (no) |
DE (1) | DE59401923D1 (no) |
DK (1) | DK0650960T3 (no) |
ES (1) | ES2101420T3 (no) |
GR (1) | GR3023177T3 (no) |
HK (1) | HK1006712A1 (no) |
IL (1) | IL111455A0 (no) |
NO (1) | NO302028B1 (no) |
NZ (1) | NZ264822A (no) |
PH (1) | PH31264A (no) |
PL (1) | PL179687B1 (no) |
RU (1) | RU2145959C1 (no) |
TW (1) | TW330202B (no) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6046219A (en) * | 1995-01-20 | 2000-04-04 | Cornell Research Foundation, Inc. | Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation |
IL135495A (en) * | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid |
AU5762896A (en) * | 1996-04-30 | 1997-11-19 | Hoechst Aktiengesellschaft | 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and the ir use as drugs |
JPH1067674A (ja) * | 1996-06-19 | 1998-03-10 | Advanced Sukin Res Kenkyusho:Kk | 細胞外マトリツクスの異常蓄積抑制剤 |
DE19746287A1 (de) * | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
US7183278B1 (en) | 1998-11-04 | 2007-02-27 | Meiji Seika Kaisha, Ltd. | Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component |
FR2803592A1 (fr) * | 2000-01-06 | 2001-07-13 | Aventis Cropscience Sa | Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant. |
WO2001092258A1 (en) * | 2000-05-30 | 2001-12-06 | Neurogen Corporation | Imidazoloisoquinolines |
CN101664408B (zh) * | 2001-12-06 | 2013-05-01 | 法布罗根股份有限公司 | 低氧诱导因子(HIF)α的稳定化 |
EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
US20030153503A1 (en) | 2001-12-06 | 2003-08-14 | Klaus Stephen J. | Methods of increasing endogenous erythropoietin (EPO) |
US7618940B2 (en) * | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
US8124582B2 (en) | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
CN102977015B (zh) | 2003-06-06 | 2015-05-06 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途 |
JP4792048B2 (ja) | 2005-03-02 | 2011-10-12 | ファイブロゲン インコーポレイティッド | チエノピリジン化合物およびその使用方法 |
US20060276477A1 (en) * | 2005-06-06 | 2006-12-07 | Fibrogen, Inc. | Treatment method for anemia |
KR20080028918A (ko) | 2005-06-15 | 2008-04-02 | 피브로겐, 인크. | 암의 치료를 위한 화합물과 방법 |
CN103382216B (zh) | 2006-01-27 | 2016-04-20 | 菲布罗根有限公司 | 使低氧诱导因子(hif)稳定的氰基异喹啉化合物 |
AU2007217474A1 (en) * | 2006-02-21 | 2007-08-30 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
CA2644850A1 (en) * | 2006-03-08 | 2007-09-13 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
CA2647596C (en) | 2006-04-04 | 2012-06-12 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
PE20080209A1 (es) * | 2006-06-23 | 2008-05-15 | Smithkline Beecham Corp | Derivados de glicina como inhibidores de prolil hidroxilasa |
AU2013231191B2 (en) * | 2006-06-23 | 2015-09-03 | Glaxosmithkline Llc | Prolyl hydroxylase inhibitors |
ES2705587T3 (es) | 2006-06-26 | 2019-03-26 | Akebia Therapeutics Inc | Inhibidores de prolil hidroxilasa y métodos de uso |
JP5352454B2 (ja) * | 2006-06-28 | 2013-11-27 | サノフイ | Cxcr2アンンタゴニスト |
JP5352455B2 (ja) * | 2006-06-30 | 2013-11-27 | サノフイ | Cxcr2阻害剤 |
CL2008000066A1 (es) * | 2007-01-12 | 2008-08-01 | Smithkline Beecham Corp | Compuestos derivados de (5-hidroxi-3-oxo-2,3-dihidropiridazina-4-carbonil)glicina, inhibidores de hif prolil hidroxilasas; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anem |
WO2009002533A1 (en) | 2007-06-27 | 2008-12-31 | The Brigham And Women's Hospital, Inc. | Inflammatory bowel disease therapies |
WO2010056767A1 (en) | 2008-11-14 | 2010-05-20 | Fibrogen, Inc. | Thiochromene derivatives as hip hydroxylase inhibitors |
JP5643233B2 (ja) | 2009-02-10 | 2014-12-17 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap | プロリルヒドロキシラーゼ阻害物質としてのキナゾリノン |
AU2010314973B9 (en) * | 2009-11-06 | 2015-03-19 | Aerpio Therapeutics Inc. | Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
WO2012106472A1 (en) | 2011-02-02 | 2012-08-09 | Fibrogen, Inc. | Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase |
CN103717214A (zh) | 2011-06-06 | 2014-04-09 | 阿克比治疗有限公司 | 用于稳定低氧诱导因子-2α作为治疗癌症的方法的化合物和组合物 |
NO2686520T3 (no) * | 2011-06-06 | 2018-03-17 | ||
MX344109B (es) | 2011-10-25 | 2016-12-05 | Janssen Pharmaceutica Nv | Formulaciones de sal de meglumina del ácido 1-(5,6-dicloro-1h-benz o[d]imidazol-2-il)-1h-pirazol-4-carboxílico. |
EP2834220B1 (en) | 2012-03-09 | 2016-11-09 | Fibrogen, Inc. | 4-hydroxy-isoquinoline compounds as hif hydroxylase inhibitors |
CN107540607A (zh) | 2012-07-16 | 2018-01-05 | 菲布罗根有限公司 | 脯氨酰羟化酶抑制剂的晶体形态 |
MY171483A (en) | 2012-07-16 | 2019-10-15 | Fibrogen Inc | Process for making isoquinoline compounds |
US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
RU2666144C2 (ru) | 2013-01-24 | 2018-09-06 | Фиброген, Инк. | Кристаллические формы { [1-циано-5-(4-хлорофенокси)-4-гидроксиизохинолин-3-карбонил]-амино} -уксусной кислоты |
ES2974273T3 (es) | 2013-06-13 | 2024-06-26 | Akebia Therapeutics Inc | Composiciones y métodos para tratar la anemia |
TWI665190B (zh) | 2013-11-15 | 2019-07-11 | 阿克比治療有限公司 | {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途 |
EP3240409A4 (en) * | 2014-12-30 | 2018-06-20 | Dow Agrosciences LLC | Picolinamides with fungicidal activity |
WO2016118858A1 (en) | 2015-01-23 | 2016-07-28 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
CN106146395B (zh) * | 2015-03-27 | 2019-01-01 | 沈阳三生制药有限责任公司 | 3-羟基吡啶化合物、其制备方法及其制药用途 |
HUE056958T2 (hu) | 2015-04-01 | 2022-04-28 | Akebia Therapeutics Inc | Készítmények és eljárások vérszegénység kezelésére |
US11713298B2 (en) | 2018-05-09 | 2023-08-01 | Akebia Therapeutics, Inc. | Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid |
CN113767089B (zh) * | 2019-04-26 | 2024-06-11 | 株式会社钟化 | 伐度司他中间体的制造方法 |
CN110305143B (zh) * | 2019-07-19 | 2021-03-09 | 济南新科医药科技有限公司 | 一种呋喃[2,3-c]并吡啶衍生物及其制备方法和用途 |
US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4015255A1 (de) * | 1990-05-12 | 1991-11-14 | Hoechst Ag | Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase |
US5192773A (en) * | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
EP0541042A1 (de) * | 1991-11-05 | 1993-05-12 | Hoechst Aktiengesellschaft | Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-10-27 DK DK94117017.7T patent/DK0650960T3/da active
- 1994-10-27 DE DE59401923T patent/DE59401923D1/de not_active Expired - Fee Related
- 1994-10-27 AT AT94117017T patent/ATE149485T1/de not_active IP Right Cessation
- 1994-10-27 EP EP94117017A patent/EP0650960B1/de not_active Expired - Lifetime
- 1994-10-27 ES ES94117017T patent/ES2101420T3/es not_active Expired - Lifetime
- 1994-10-28 PH PH49264A patent/PH31264A/en unknown
- 1994-10-28 PL PL94305647A patent/PL179687B1/pl unknown
- 1994-10-30 IL IL11145594A patent/IL111455A0/xx unknown
- 1994-10-31 US US08/332,824 patent/US5658933A/en not_active Expired - Lifetime
- 1994-10-31 NZ NZ264822A patent/NZ264822A/en unknown
- 1994-10-31 AU AU77566/94A patent/AU689135B2/en not_active Ceased
- 1994-11-01 CZ CZ19942682A patent/CZ287767B6/cs not_active IP Right Cessation
- 1994-11-01 NO NO944161A patent/NO302028B1/no not_active IP Right Cessation
- 1994-11-01 RU RU94040163A patent/RU2145959C1/ru active
- 1994-11-01 CA CA002134865A patent/CA2134865A1/en not_active Abandoned
- 1994-11-02 CN CN94117622A patent/CN1084736C/zh not_active Expired - Fee Related
- 1994-11-02 JP JP6292031A patent/JPH07224039A/ja not_active Abandoned
- 1994-11-02 KR KR1019940028870A patent/KR950014069A/ko not_active Application Discontinuation
- 1994-12-05 TW TW083111258A patent/TW330202B/zh active
-
1997
- 1997-04-18 GR GR970400836T patent/GR3023177T3/el unknown
-
1998
- 1998-06-22 HK HK98105874A patent/HK1006712A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2134865A1 (en) | 1995-05-03 |
RU2145959C1 (ru) | 2000-02-27 |
US5658933A (en) | 1997-08-19 |
IL111455A0 (en) | 1994-12-29 |
PL179687B1 (pl) | 2000-10-31 |
TW330202B (en) | 1998-04-21 |
GR3023177T3 (en) | 1997-07-30 |
NO302028B1 (no) | 1998-01-12 |
PH31264A (en) | 1998-06-18 |
KR950014069A (ko) | 1995-06-15 |
CZ287767B6 (en) | 2001-01-17 |
RU94040163A (ru) | 1997-02-20 |
ATE149485T1 (de) | 1997-03-15 |
EP0650960B1 (de) | 1997-03-05 |
NO944161L (no) | 1995-05-03 |
DK0650960T3 (da) | 1997-09-01 |
CN1107144A (zh) | 1995-08-23 |
DE59401923D1 (de) | 1997-04-10 |
AU7756694A (en) | 1995-05-18 |
HK1006712A1 (en) | 1999-03-12 |
JPH07224039A (ja) | 1995-08-22 |
AU689135B2 (en) | 1998-03-26 |
PL305647A1 (en) | 1995-05-15 |
CZ268294A3 (en) | 1995-05-17 |
ES2101420T3 (es) | 1997-07-01 |
NZ264822A (en) | 1997-02-24 |
CN1084736C (zh) | 2002-05-15 |
EP0650960A1 (de) | 1995-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO944161D0 (no) | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel | |
NO944162L (no) | Substituerte heterosykliske karboksylsyreamider, deres fremstilling og deres anvendelse som legemiddel | |
NO945084L (no) | Substituerte heterocykliske karboksylsyreamider, deres fremstilling og anvendelse som legemiddel | |
HUT70836A (en) | 1-h-indole-3-acetamide spla2 inhibitors, process for producing them and pharmaceutical compositions comprising same compounds | |
NO951147L (no) | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel | |
AU686104B2 (en) | Substituted amidinonaphthyl ester derivatives | |
ES2147499A1 (es) | Derivados de acidos carboxilicos, metodo para su elaboracion y agentes terapeuticos que contienen estos compuestos. | |
MY112414A (en) | Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN MAY 2003 |